Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

The League of Legends 13.2 Update is coming, and bringing with it a deluge of changes and tweaks to better balance Champions and the game overall. This page acts as a comprehensive breakdown of all ...